Cargando…
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
Mature B-cell non-Hodgkin lymphoma is the most common subtype of non-Hodgkin lymphoma in childhood and adolescence. B-cell non-Hodgkin lymphomas are further classified into histological subtypes, with Burkitt lymphoma and Diffuse large B-cell lymphoma being the most common subgroups in pediatric pat...
Autores principales: | Rohde, Marius, Bonn, Bettina R., Zimmermann, Martin, Lange, Jonas, Möricke, Anja, Klapper, Wolfram, Oschlies, Ilske, Szczepanowski, Monika, Nagel, Inga, Schrappe, Martin, Loeffler, Markus, Siebert, Reiner, Reiter, Alfred, Burkhardt, Birgit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451341/ https://www.ncbi.nlm.nih.gov/pubmed/28209658 http://dx.doi.org/10.3324/haematol.2016.156885 |
Ejemplares similares
-
Second malignancies after treatment of childhood non-Hodgkin lymphoma – a report of the Berlin-Frankfurt-Muenster study group
por: Moser, Olga, et al.
Publicado: (2020) -
Outcomes of dose-adjusted Berlin–Frankfurt–Münster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma
por: Xie, Yan, et al.
Publicado: (2015) -
Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2015) -
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group
por: Niktoreh, Naghmeh, et al.
Publicado: (2019) -
Acquisition of TCF3 and CCND3 Mutations and Transformation to Burkitt Lymphoma in a Case of B-Cell Prolymphocytic Leukemia
por: Nguyen-Khac, Florence, et al.
Publicado: (2021)